- Home
- SVRA vs GRVY Comparison
SVRA vs GRVY Comparison
Compare SVRA & GRVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- GRVY
- Stock Information
- Founded
- SVRA N/A
- GRVY 2000
- Country
- SVRA United States
- GRVY South Korea
- Employees
- SVRA N/A
- GRVY N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- GRVY Business Services
- Sector
- SVRA Health Care
- GRVY Consumer Discretionary
- Exchange
- SVRA Nasdaq
- GRVY Nasdaq
- Market Cap
- SVRA 458.2M
- GRVY 430.3M
- IPO Year
- SVRA N/A
- GRVY 2005
- Fundamental
- Price
- SVRA $2.69
- GRVY $60.52
- Analyst Decision
- SVRA Buy
- GRVY
- Analyst Count
- SVRA 7
- GRVY 0
- Target Price
- SVRA $9.86
- GRVY N/A
- AVG Volume (30 Days)
- SVRA 633.7K
- GRVY 17.8K
- Earning Date
- SVRA 03-06-2025
- GRVY 11-12-2024
- Dividend Yield
- SVRA N/A
- GRVY N/A
- EPS Growth
- SVRA N/A
- GRVY N/A
- EPS
- SVRA N/A
- GRVY 9.14
- Revenue
- SVRA N/A
- GRVY $381,080,758.00
- Revenue This Year
- SVRA N/A
- GRVY N/A
- Revenue Next Year
- SVRA N/A
- GRVY N/A
- P/E Ratio
- SVRA N/A
- GRVY $6.62
- Revenue Growth
- SVRA N/A
- GRVY N/A
- 52 Week Low
- SVRA $2.59
- GRVY $57.37
- 52 Week High
- SVRA $5.70
- GRVY $88.85
- Technical
- Relative Strength Index (RSI)
- SVRA 40.81
- GRVY 41.49
- Support Level
- SVRA $2.65
- GRVY $60.05
- Resistance Level
- SVRA $2.91
- GRVY $64.41
- Average True Range (ATR)
- SVRA 0.11
- GRVY 1.54
- MACD
- SVRA 0.01
- GRVY -0.18
- Stochastic Oscillator
- SVRA 23.08
- GRVY 11.48
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.